Top 10 Heal Care Stocks To Own For 2018

By Scott Tzu with Parke Shall

When a company is in a distressed situation, a lot of times it’s not going to come out and tell the public that it is looking at a reorganization or considering filing bankruptcy. As investors, we are often left to draw our own conclusions based on piecemeal that we can obtain regarding the company in question. We believe the signs and signals continue to indicate to us that Concordia Healthcare (NASDAQ:CXRX) is not a stock to be in, has limited turnaround prospects, and could very well be heading for restructuring.

By now, most readers will find themselves familiar with the CXRX story, but for those who are not, we will give you a small briefing. Concordia is one of many pharmaceutical companies that tried to expand by rolling up other corporations once the cost of debt became very cheap. It used a hybrid style pricing model, where it raised the price of several key drugs after acquiring them in order to bet it all on the company’s future cash flows instead of the mounting pile of debt that the company was accruing. When presenting earnings each quarter, CXRX used similar non-GAAP accounting treatments to give the impression that acquisition costs and one time costs would not be a factor. Now, like Valeant (NYSE:VRX), as questions start to rise about the company’s product line, all eyes turn to the balance sheet, which is in severe distress.

Top 10 Heal Care Stocks To Own For 2018: Outerwall Inc.(OUTR)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix at all time highswhile potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,was swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of Outerwall (NASDAQ: OUTR) were down 16.03 percent to $47.00 after the company lowered its forecast for the third quarter and full year. Werner Enterprises (NASDAQ: WERN) shares tumbled 4.71 percent to $23.26 after the company issued a weak third-quarter profit forecast. Bank of America downgraded the stock from Buy to Neutral. Pandora Media (NYSE: P) down, falling 1.71 percent to $23.58 as the company announced its plans to sell 14 million shares of common stock, including 4 million shares from current stockholders.

  • [By Monica Gerson]

    Shares of Outerwall Inc (NASDAQ: OUTR) surged over 8 percent in Monday’s after-hours trading session following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall’s Board also announced the raising of the company’s quarterly dividend from $0.30 to $0.60 per share. Outerwall shares jumped 8.11 percent to $37.18 in the after-hours trading session.

  • [By Monica Gerson]

    Outerwall (NASDAQ: OUTR) dipped 19.33% to $45.15 in the pre-market session after the company lowered its forecast for the third quarter and full year.

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix close to all time highsgoing into earnings while potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,got swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

Top 10 Heal Care Stocks To Own For 2018: Liberty Interactive Corporation(LVNTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of General Communication, Inc. (NASDAQ: GNCMA) got a boost, shooting up 63 percent to $33.43 after Liberty Interactive Corporation (NASDAQ: LVNTA) announced plans to acquire General Communication for $1.12 billion.

Top 10 Heal Care Stocks To Own For 2018: Spark Networks, Inc.(LOV)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap dating site stock Match Group Inc (NASDAQ: MTCH), which was spun off from media and Internet stock IAC/InterActiveCorp (NASDAQ: IAC) and is a peer or remaining dating stock Spark Networks Inc (NYSEMKT: LOV), is the eight most shorted stock on theNASDAQ with short interest of 43.96% according to Highshortnterest.com.

Top 10 Heal Care Stocks To Own For 2018: Washington Federal, Inc.(WAFD)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

Top 10 Heal Care Stocks To Own For 2018: Huntsman Corporation(HUN)

Advisors’ Opinion:

  • [By Lee Jackson]

    Huntsman Corp. (NYSE: HUN) had its executive chairman selling stock last week. Jon Huntsman parted with 600,000 shares, and the share priceranged from $17.25 to $17.27. The total for the trade was posted at $10 million.The company manufactures and sells differentiated organic and inorganic chemical products worldwide. The stock traded Friday at $18.10, so some left on that table as well.

  • [By Paul Ausick]

    Venator Materials PLC is a maker of titanium dioxide pigments and additives. The company is being spun out of Huntsman Corp. (NYSE: HUN) and plans to offer 22.7 million shares in an expected price range of $20 to $21, raising $465 million at an implied market cap of $2.18 billion. Underwriters include Citi, Goldman Sachs, BofA/Merrill Lynch, J.P. Morgan, Barclays, Deutsche Bank, UBS Investment Bank, RBC Capital Markets, Moelis & Company, HSBC Corp., Nomura Securities, SunTrust Robinson Humphrey, Academy Securities, and Commerzbank Capital. Shares are scheduled to price Wednesday and begin trading Thursday on the New York Stock Exchange under the ticker symbol VNTR.

Top 10 Heal Care Stocks To Own For 2018: Helmerich & Payne, Inc.(HP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Western Digitalnow expects Dec-Q revenue of $4.75Bn, gross margin of 36%, tax rate of 13%, and EPS between $2.10-$2.15; versus ~$4.71Bn, 36%, 14-16%, and $1.85-$1.95, respectively. We believe that the Dec-Q guidance update is mostly attributed to the resolution of IP disputes with Samsung and better-than-expected execution by Western Digital; meaning, we do not expect much read-through benefit forSeagate Technology (STX) or HP Inc (HP) (both Equal Weight-rated stocks)…

  • [By Reuben Gregg Brewer]

    Helmerich & Payne, Inc.(NYSE:HP) has an impressive dividend record, particularly when you take into consideration that it operates in the highly cyclical oil and gas services industry. The problem for investors, though, is that a dividend decision a few years ago obscures the income story here. This is one stock where the trend isn’t what it seems, and a little more analysis is needed to understand Helmerich & Payne’s true dividend potential.

  • [By Reuben Gregg Brewer]

    The energy sector is feeling the pinch of low oil and natural gas prices, which has been a headwind for oil field services industry stalwart Helmerich & Payne, Inc. (NYSE:HP) and dragged down investor sentiment for midstream sector players Enterprise Products Partners L.P. (NYSE:EPD) and Buckeye Partners, L.P. (NYSE:BPL). But each of these companies has a long history of increasing dividends annually, which means that the bad news today is likely to be good news for dividend lovers looking for big yields.

  • [By Wayne Duggan]

    While Loop maintains a Buy rating on all of the stocks mentioned above, Guggenheim analyst Michael LaMotte isn’t quite so bullish on the sector. Earlier this week, LaMotte downgraded the following oil services stocks from Buy to Neutral:

    Baker Hughes Incorporated (NYSE: BHI)
    Fairmount Santrol Holdings Inc (NYSE: FMSA)
    Helmerich & Payne, Inc. (NYSE: HP)
    Nabors Industries Ltd. (NYSE: NBR)
    Schlumberger Limited. (NYSE: SLB)
    Halliburton
    Superior Energy Services

    Guggenheim also cut its 2017 oil price forecast from $55 to $48/bbl.

Top 10 Heal Care Stocks To Own For 2018: Marathon Oil Corporation(MRO)

Advisors’ Opinion:

  • [By Dustin Blitchok]

    Marathon Oil Corporation (NYSE: MRO) was upgraded from Neutral to Positive at Susquehanna on Friday after the oil giant sold off its Canadian subsidiary for $2.5 billion and bought 71,000 acres of oil fields in New Mexico for $1.1 billion.

  • [By Ben Levisohn]

    Marathon Oil (MRO) tumbled to the bottom of the S&P 500 today after oil tumbled after data pointed to higher inventories of crude.

    Agence France-Presse/Getty Images

    Marathon Oildropped 8.7% to $14.87, while the S&P 500 fell 0.2% to 2,362.98, as Front Month Nymex Crude futures for April delivery slid 5.4% to $50.28., leading some to wonder if the price oil could drop below $50 a barrel.

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

    The oil rout began after the U.S. Energy Information Administration reported that U.S. oil inventories rose by 8.2 million barrels to reach $518.4 million, a record level.

    Marathon Oil’s market capitalization fell to $12.6 billion today from $13.8 billion yesterday. It reported a net loss of $2.1 billion on sales of $4.1 billion in 2016.

  • [By WWW.THESTREET.COM]

    Cramer said he tried to buck this trend by investing in EOG Resources (EOG) and Marathon Oil (MRO) but was wrong on both counts. In the case of EOG, even having the best properties wasn’t enough to ward off the collapse in oil prices. Meanwhile, Marathon’s decision to spin off its refining business left it with no cushion to stem its losses.

  • [By Paul Ausick]

    Marathon Oil Corp. (NYSE: MRO) dropped about 1.6% Friday to post a new 52-week low of $11.41 after closing Thursday at $11.59. The 52-week high is $19.28. Volume was about 30% lower than the daily average of about 13.7 million shares. The company had no specific news.

  • [By Shanthi Rexaline]

    The bulking up strategy did not work well for the company over the years, as it saw its market share dwindle and profitability erode. In 1982, in a diversification bid, the company picked up Marathon Oil Corporation (NYSE: MRO) and renamed itself as USX.

  • [By Paul Ausick]

    Marathon Oil Corp. (NYSE: MRO) dropped about 1.7% Tuesday to post a new 52-week low of $11.33 after closing Monday at $11.53. The 52-week high is $19.28. Volume was nearly 50% higher than the daily average of about 13.7 million shares. The company had no specific news.

Top 10 Heal Care Stocks To Own For 2018: Ternium S.A.(TX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Ternium SA (NYSE:TX) jumped on Wednesday: up more than 10% by 2:30 p.m. EST. While the steelmaker reported weaker-than-expected earnings after the closing bell yesterday, it provided optimistic guidance and announced a compelling acquisition.

Top 10 Heal Care Stocks To Own For 2018: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

  • [By Jim Robertson]

    Yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announcedthe filing of an international patent application that describes compounds discovered to be effective for neural repair treatments. The underlying patent rights were assigned to Vitality Biopharma in March 2016 and are based on work performed by the Myelin Repair Foundation (MRF) -a non-profit disease research organization that was dedicated to developing regenerative therapies for multiple sclerosis.

Top 10 Heal Care Stocks To Own For 2018: Fifth Street Asset Management Inc.(FSAM)

Advisors’ Opinion:

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

  • [By Jordan Wathen]

    Last week,The Wall Street Journal broke the news that Fifth Street Asset Management (NASDAQ:FSAM) was on the auction block, apparently for the second time.

Leave a Reply

Your email address will not be published. Required fields are marked *